dimethyl fumarate accord
accord healthcare s.l.u. - dimetylfumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
arbicen 240 mg
egis pharmaceuticals plc, maďarsko - dimetyl-fumarát - 59 - immunopraeparata
arbicen 120 mg
egis pharmaceuticals plc, maďarsko - dimetyl-fumarát - 59 - immunopraeparata
dimtelzo 240 mg
sandoz d.d., slovinsko - dimetyl-fumarát - 59 - immunopraeparata
dimtelzo 120 mg
sandoz d.d., slovinsko - dimetyl-fumarát - 59 - immunopraeparata
nideolo 120 mg
pharmathen s.a., grécko - dimetyl-fumarát - 59 - immunopraeparata
dimethyl fumarate glenmark 240 mg
glenmark pharmaceuticals s.r.o., Česká republika - dimetyl-fumarát - 59 - immunopraeparata
dimethyl fumarate glenmark 120 mg
glenmark pharmaceuticals s.r.o., Česká republika - dimetyl-fumarát - 59 - immunopraeparata
adifemu 120 mg
vipharm s.a., poľsko - dimetyl-fumarát - 59 - immunopraeparata
adifemu 240 mg
vipharm s.a., poľsko - dimetyl-fumarát - 59 - immunopraeparata